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Deciding on the number of psychotherapy sessions to 
satisfactorily treat a patient is a vital clinical as well as eco-
nomic issue in most mental health systems worldwide. 
The length of outpatient psychotherapy in naturalistic 
conditions ranges from a single session to hundreds of 
sessions [1]. In randomized clinical trials, the number of 
sessions is typically fixed to deliver manualized treat-
ments and to control for dosage effects (e.g., in a 16-ses-
sion format [2]). Using data from Routine Outcome 
Monitoring studies [3, 4], we investigated whether the 
treatments under naturalistic conditions were fixed to a 
particular number of sessions or not (H1), whether natu-
ralistic conditions tended to include unusually long treat-
ments (e.g., > 100 sessions) (H2), and how the observed 
number of sessions was distributed across countries (H3).
Based on a systematic review, we identified 20 natural-
istic samples across eight countries (published between 
2015 and 2019; see Table 1). In individual therapy (k = 
17), the number of sessions was not fixed, whereas the 
three studies that referred to a fixed number of sessions 
were manualized group or family therapy programs. In all 
samples, the mean number of sessions (MNS) was lower 
than 50 sessions with a range from 2.86 to 45.1 sessions 
(MNS mean = 12.90 sessions, MNS median = 8.21 ses-
sions, skewness = 1.71; Shapiro-Wilk, p < 0.001). More-
over, the MNS in individual therapy appears to be influ-
enced by country-specific policies of mental health sys-
tems. Whereas in some systems the maximum sessions 
are mandated (e.g., contingent of max. 8 or 20 sessions in 
the UK), other systems have more liberal policies (e.g., 
Switzerland with time-unlimited policies), sometimes 
impacted by the particular funding scheme of the private 
or mandatory health insurances. In most samples, the 
MNS did not exceed the common 16-session format of 
manualized conditions, except for German samples 
where the policies allow for a considerably large number 
of sessions (t = 9.60, p < 0.001; with a contingent of more 
than 100 sessions for some treatments).
We observed three different prototypes in which treat-
ment duration is determined: fixed session numbers, 
contingent of session maximum, and collaboratively ne-
gotiated session number. These different prototypes and 
its hybrid forms are likely to influence expectations about 
a particular number of sessions needed. Naturalistic set-
tings most often apply custom-tailored and collaborative-
ly negotiated session numbers, targeted at the patient’s 
problems, needs, preferences, time resources, and treat-
ment progress as well as financial resources. In practice, 
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Table 1. Mean number of sessions under naturalistic conditions (studies published between 2015 and 2019)
Author Country Manualized 
session 
 number
Maximum of 
sessions
Type of naturalistic condition
(condition x/y)
Sample 
size
MNS
Brattland  
et al., 2018
Norway no Not declared Routine outcome monitoring feedback/treatment as 
usual
85/85 13.01/12.04
Burlingame  
et al., 2018
USA yes Fixed 12 Routine outcome monitoring feedback, group feedback/
usual feedback
59/67 9.86/10.0
Carr et al.,
2017
USA no <270 Routine outcome monitoring feedback 132 23.0
Davidson  
et al., 2017
UK no Not declared Clinical outcomes in routine evaluation, feedback 
 supervision/usual supervision
58/67 10.19
Delgadillo  
et al., 2017
UK no Contingent 8 or 20 Routine outcome monitoring feedback, before and after 
feedback study
349/245 10.25/6.59
Delgadillo  
et al., 2018
UK no Contingent 8 or 20 Routine outcome monitoring feedback, feedback/no 
feedback
1,176/1,057 6.54/6.35
Eeren et al., 
2018
The  
Netherlands
no Not declared Routine outcome monitoring, multisystemic therapy or 
functional family therapy
697 7.96
Flückiger  
et al., 2019
Switzerland no <170 General change mechanism feedback 430 30.1
Gmeinwieser  
et al., 2019
Germany no Contingent up to 95 General change mechanism feedback 911 45.08
Hales et al., 
2018
UK no Not declared Routine mood monitoring feedback 11 6.27
Haugen  
et al., 2015
USA no Not declared Routine outcome monitoring feedback 36 18.58
Hewison  
et al., 2016
UK no <151 Clinical outcomes in routine evaluation – outcome 
monitoring
877 23.3
Lutz et al., 
2015
Germany no Contingent up to 95 Routine outcome monitoring feedback, feedback/no 
feedback
507/244 42.71/36.18
Malins  
et al., 2019
UK no <17 Outcome rating scale feedback, cognitive behavioral 
therapy/treatment as usual
56/23 8.08
Mechler and  
Holmqvist, 2015
Sweden no Not declared Clinical outcomes in routine evaluation, primary care/
specialist psychiatry
840/317 6.01/7.65
Schuman  
et al., 2015
USA yes Fixed 5 Outcome rating scale feedback/treatment as usual 137/126 4.16/3.55 
She et al., 
2018
China no Not declared Routine outcome monitoring feedback/treatment as 
usual
101/85 4.78/5.51
Tilden et al., 
2019
Norway no <22 Routine outcome monitoring feedback or treatment as 
usual
328 5.66
Wise and  
Streiner, 2018
USA no <26 Routine outcome monitoring feedback/treatment as 
usual
82/79 15.91/15.08 
Wolchik  
et al., 2016
USA yes Fixed 11+2 Family routine inventory feedback/literature condition 164/76 2.86/3.0
References of the primary studies can be requested from the first author. MNS, mean number of sessions ; Manualized treatments , treatments refer to 
an a priori defined number of (manualized) sessions; Maximum of sessions, maximum of sessions reported in the primary studies; Fixed, fixed session num-
ber (defined a priori); Contingent, contingent of a maximum of sessions covered by mental health systems; <x/y, maximum of sessions observed in primary 
studies where session numbers were not declared as strictly fixed or contingented; Not declared, no maximum of sessions reported in the primary study. 
Systematic search performed on February 12, 2020 in Medline, PsycInfo, and Psyndex with the keywords “psychotherapy” or “psychological therapy” 
combined with “Routine Outcome Monitoring,” for articles published between 2015 and 2019. A total of 169 articles were identified, of which 59 referred 
to empirical data in the abstract. Seventeen studies reported a central tendency of the number of sessions (e.g., mean number of sessions). Contact of further 
five corresponding authors of included studies that did not report the mean number of sessions, resulting in three additional studies and an overall sample 
of 20 studies across eight countries.
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treatment duration substantially depends on treatment 
progress and dropout rates [5–7].
There is little convergence across countries (and their 
policies) regarding how treatment duration should be 
decided. We urge for more precise empirical answers 
about how much psychological treatment is necessary for 
whom under naturalistic conditions. We also urge re-
searchers and clinicians to exercise caution when gener-
alizing conclusions regarding the optimal number of ses-
sions across countries. Long-term research programs are 
needed to better understand how psychotherapy policies, 
expectations about required sessions, measurement of 
treatment progress, and the degree of collaborative nego-
tiation may influence treatment duration and its effect 
on long-term efficacy and cost-effectiveness [8, 9]. We 
underscore the relevance of cross-cultural scientific soci-
eties, such as the International Federation for Psycho-
therapy (IFP) or the International Society of Psychother-
apy (SPR), to consolidate evidence-based psychotherapy 
knowledge across particular countries and psychothera-
py orientations.
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